MR

Maurice R. Greenberg

Description

Maurice R. Greenberg - Chairman & Managing Director @ Starr Companies

Investor Profile

Maurice R. Greenberg has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in Israel.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Series C (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Maurice R. Greenberg frequently co-invest with?

TV
North America, California, United States, San Francisco
Co-Investments: 1
NDFOS
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

Which angels does Maurice R. Greenberg often collaborate with?

Shared Deals: 1

What are some of recent deals done by Maurice R. Greenberg?

NeoTX Therapeutics

Rehovot, HaMerkaz, Israel

NeoTX Therapeutics is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy.

BiotechnologyHealth CareHealth DiagnosticsMedicalOncologyTherapeutics
Series CFeb 19, 2020
Amount Raised: $45,000,000

Find More Investors Like Maurice R. Greenberg

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Maurice R. Greenberg | Pipeseed